| miRNA | KEGG pathway | value | Target genes |
| miR-155-5p, miR-15a-5p, let-7c-5p, miR-106b-5p, let-7b-5p, miR-27b-9p | Acute myeloid leukemia | 0.0280 | 8 | miR-15a-5p, miR-425-5p | Aldosterone-regulated sodium reabsorption | 0.0143 | 4 | miR-29b-3p, miR-29a-3p, miR-24-3p | Amoebiasis | 0.0000 | 6 | miR-155-5p, miR-503-5p, miR-16-5p, miR-425-5p | Apoptosis | 0.0008 | 6 | miR-140-5p, let-7b-5p, miR-24-3p | Axon guidance | 0.0007 | 9 | miR-15a-5p, let-7b-5p | B cell receptor signaling pathway | 0.0029 | 7 | miR-29a-3p | Bacterial invasion of epithelial cells | 0.0296 | 1 | miR-425-5p | Carbohydrate digestion and absorption | 0.0091 | 4 | miR-15a-5p, miR-425-5p, miR-24-3p, miR-23b-3p, miR-27b-13p | Chagas disease (American trypanosomiasis) | 0.0020 | 9 | miR-335-5p, miR-15a-5p, let-7c-5p, let-7b-5p, miR-425-5p, miR-23b-3p, miR-27b-3p, miR-27a-3p | Chronic myeloid leukemia | 0.0061 | 10 | miR-425-5p | Circadian rhythm | 0.0032 | 3 | miR-503-5p, miR-15a-5p, let-7c-5p, miR-16-5p, let-7b-5p, miR-425-5p, miR-24-3p, miR-23b-3p, miR-27b-6p | Colorectal cancer | 0.0007 | 9 | miR-29b-3p, miR-29a-3p, miR-27a-3p | Cysteine and methionine metabolism | 0.0012 | 2 | miR-503-5p, let-7a-5p, miR-29b-3p | Cytokine-cytokine receptor interaction | 0.0002 | 3 | miR-155-5p | Cytosolic DNA-sensing pathway | 0.0052 | 2 | let-7d-5p, miR-425-5p, miR-24-3p | Dopaminergic synapse | 0.0045 | 9 | miR-15a-5p | Dorsoventral axis formation | 0.0105 | 3 | miR-29b-3p, miR-29a-3p | ECM-receptor interaction | 0.0000 | 5 | miR_142-3p, miR-425-5p | Endocrine and other factor-regulated calcium reabsorption | 0.0216 | 1 | miR-15a-5p, let-7c-5p, let-7b-5p, miR-425-5p | Endometrial cancer | 0.0012 | 6 | miR-155-5p, miR-335-5p, miR-106b-5p | Epstein-Barr virus infection | 0.0240 | 3 | miR-15a-5p | Fatty acid biosynthesis | 0.0000 | 1 | miR-15a-5p | Fc gamma R-mediated phagocytosis | 0.0103 | 7 | miR-15a-5p, miR-16-5p, miR-29b-3p, miR-29a-3p, let-7b-5p, mmu-miR-425-5p | Focal adhesion | 0.0105 | 12 | miR_142-3p, let-7b-5p, miR-425-5p | GABAergic synapse | 0.0216 | 9 | miR_142-3p, miR-15a-5p, miR-425-5p | Gap junction | 0.0230 | 7 | miR_142-3p, miR-425-5p, miR-24-3p | Gastric acid secretion | 0.0216 | 5 | miR-15a-5p | Glycosaminoglycan biosynthesis-heparan sulfate/heparin | 0.0000 | 3 | miR-15a-5p | Glycosphingolipid biosynthesis-globo series | 0.0209 | 2 | miR-15a-5p, let-7b-5p, miR-24-3p | Glycosphingolipid biosynthesis-lacto and neolacto series | 0.0004 | 3 | let-7b-5p | Glycosylphosphatidylinositol (GPI)-anchor biosynthesis | 0.0017 | 3 | miR_142-3p, miR-15a-5p, miR-106b-5p, miR-24-3p | GnRH signaling pathway | 0.0216 | 6 | miR-16-5p, miR-106b-5p, miR-425-5p | Hedgehog signaling pathway | 0.0454 | 5 | miR-503-5p, miR-335-5p, miR-15a-5p, let-7c-5p, miR-16-5p, miR-106b-5p, miR-20a-5p, let-7b-5p, miR-425-5p | Hepatitis B | 0.0008 | 14 | miR-155-5p, miR-15a-5p, miR-106b-5p, miR-20a-5p, let-7b-5p | Hepatitis C | 0.0339 | 9 | miR-155-5p | Herpes simplex infection | 0.0145 | 3 | miR-503-5p, miR-199a-5p, miR-15a-5p, miR-24-3p | HIF-1 signaling pathway | 0.0175 | 2 | miR-155-5p, miR-335-5p, let-7c-5p, miR-23b-3p, miR-27b-12p | HTLV-I infection | 0.0145 | 3 | miR-155-5p, iR-15a-5p, miR-425-5p | Insulin signaling pathway | 0.0339 | 10 | miR-155-5p, miR-140-5p | Intestinal immune network for IgA production | 0.0339 | 2 | miR-15a-5p, miR-425-5p, miR-24-3p | Long-term depression | 0.0005 | 7 | miR-15a-5p, miR-24-3p | Lysine degradation | 0.0196 | 4 | let-7d-5p, let-7b-5p, miR-425-5p | MAPK signaling pathway | 0.0073 | 12 | miR-503-5p, let-7a-5p | Measles | 0.0435 | 2 | miR-199a-5p, miR-15a-5p, miR-425-5p | mTOR signaling pathway | 0.0006 | 6 | miR-155-5p, miR-140-5p | NF-kappa B signaling pathway | 0.0038 | 2 | miR-503-5p | p53 signaling pathway | 0.0047 | 2 | miR-155-5p, miR-503-5p, miR-199a-5p, miR-15a-5p, let-7c-5p, miR-16-5p, miR-106b-5p, miR-20a-5p, let-7b-5p, miR-425-5p, miR-23b-3p, miR-27b-4p, miR-27a-3p | Pathways in cancer | 0.0064 | 20 | miR-503-5p, miR-15a-5p, miR-16-5p, miR-29b-3p, miR-29a-3p | PI3K-AKT signaling pathway | 0.0060 | 18 | miR-29b-3p, miR-29a-3p | Protein digestion and absorption | 0.0000 | 5 | miR_142-3p, miR-106b-5p, miR-425-5p, miR-24-3p | Retrograde endocannabinoid signaling | 0.0207 | 7 | miR-15a-5p, let-7b-5p | T cell receptor signaling pathway | 0.0392 | 7 | miR-503-5p, miR-15a-5p, let-7c-5p, miR-140-5p, miR-34c-5p, miR-29b-3p, miR-24-3p, miR-23b-3p, miR-27b-3p | TGF-beta signaling pathway | 0.0000 | 6 | miR-155-5p | Toll-like receptor signaling pathway | 0.0000 | 4 | miR-155-5p, miR-503-5p, miR-16-5p, miR-106b-5p, miR-20a-5p | Toxoplasmosis | 0.0294 | 2 | miR-155-5p, miR-503-5p, miR-196a-5p, let-7a-5p, let-7c-5p, miR-34c-5p, miR-27b-5p, miR-27a-3p | Transcriptional misregulation in cancer | 0.0052 | 3 | miR-155-5p | Tuberculosis | 0.0072 | 3 | miR_142-3p, miR-15a-5p | Vasopressin-regulated water reabsorption | 0.0207 | 5 | miR-15a-5p, miR-425-5p, miR-106b-5p | VEGF signaling pathway | 0.0045 | 6 | miR-503-5p, miR-335-5p | Viral carcinogenesis | 0.0044 | 3 | let-7c-5p, miR-140-5p, miR-16-5p, miR-24-3p, miR-23b-3p, miR-27b-11p | Wnt signaling pathway | 0.0398 | 6 |
|
|